Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Confo Therapeutics
Confo Therapeutics Secures VLAIO Grant Supporting Drug Discovery & Development in Endocrine and Metabolic Diseases
March 28, 2024
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer
September 12, 2023
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman
August 29, 2023
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera
June 15, 2023
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
March 30, 2023
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554
March 02, 2023
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics’ Scientific Founder Jan Steyaert Receives Prestigious Gabbay Award for Contributions to Structural Biology
October 28, 2022
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Announces Poster Presentations on CFTX-1554 Preclinical Profiling and Mechanism of Action at the IASP 2022 World Congress on Pain
September 15, 2022
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody® Drug Discovery and Development Technology in Rare Diseases
June 28, 2022
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Expands Patent Estate for ConfoBody®-based GPCR Screening Platform
December 15, 2021
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Enters Collaborative Agreement with Regeneron
November 30, 2021
From
Confo Therapeutics
Via
Business Wire
Confo Therapeutics Establishes Medical Advisory Board
June 10, 2021
From
Confo Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.